Page 24 - AN-3-3

Advanced Neurology Alzheimer’s and Parkinson’s disease rodent models

100. Huynh TP V, Wang C, Tran AC, et al. Lack of hepatic apoE mechanism. Mol Neurobiol. 2016;53(3):1741-1752.
does not influence early Aβ deposition: Observations doi: 10.1007/s12035-015-9132-3
from a new APOE knock-in model. Mol Neurodegener.
2019;14(1):37. 111. Akhtar A, Sah SP. Insulin signaling pathway and related
molecules: Role in neurodegeneration and Alzheimer’s
doi: 10.1186/s13024-019-0337-1
disease. Neurochem Int. 2020;135:104707.
101. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. doi: 10.1016/j.neuint.2020.104707
Generation of mice carrying a mutant apolipoprotein E gene
inactivated by gene targeting in embryonic stem cells. Proc 112. Akhtar A, Gupta SM, Dwivedi S, Kumar D, Shaikh MF, Negi A.
Natl Acad Sci. 1992;89(10):4471-4475. Preclinical models for Alzheimer’s disease: Past, present, and
future approaches. ACS Omega. 2022;7(51):47504-47517.
doi: 10.1073/pnas.89.10.4471
doi: 10.1021/acsomega.2c05609
102. Denk F, Wade-Martins R. Knock-out and transgenic mouse
models of tauopathies. Neurobiol Aging. 2009;30(1):1-13. 113. Dhapola R, Kumari S, Sharma P, HariKrishnaReddy D.
Insight into the emerging and common experimental
doi: 10.1016/j.neurobiolaging.2007.05.010
in-vivo models of Alzheimer’s disease. Lab Anim Res.
103. Andorfer C, Kress Y, Espinoza M, et al. 2023;39(1):33.
Hyperphosphorylation and aggregation of tau in mice doi: 10.1186/s42826-023-00184-1
expressing normal human tau isoforms. J Neurochem.
2003;86(3):582-590. 114. Ravelli KG, Rosário BDA, Camarini R, Hernandes MS,
Britto LR. Intracerebroventricular streptozotocin as
doi: 10.1046/j.1471-4159.2003.01879.x
a model of Alzheimer’s disease: Neurochemical and
104. Morley JE. The SAMP8 mouse: A model of Alzheimer behavioral characterization in mice. Neurotox Res.
disease? Biogerontology. 2002;3(1-2):57-60. 2017;31(3):327-333.
doi: 10.1023/a:1015207429786 doi: 10.1007/s12640-016-9684-7
105. Miyamoto M, Kiyota Y, Yamazaki N, et al. Age-related changes 115. Rapaka D, Adiukwu PC, Bitra VR. Experimentally induced
in learning and memory in the senescence-accelerated mouse animal models for cognitive dysfunction and Alzheimer’s
(SAM). Physiol Behav. 1986;38(3):399-406. disease. MethodsX. 2022;9:101933.
doi: 10.1016/0031-9384(86)90112-5 doi: 10.1016/j.mex.2022.101933
106. Yagi H, Katoh S, Akiguchi I, Takeda T. Age-related 116. Eisele YS, Bolmont T, Heikenwalder M, et al. Induction of
deterioration of ability of acquisition in memory and cerebral β-amyloidosis: Intracerebral versus systemic Aβ
learning in senescence accelerated mouse: SAM-P/8 as an inoculation. Proc Natl Acad Sci. 2009;106(31):12926-12931.
animal model of disturbances in recent memory. Brain Res. doi: 10.1073/pnas.0903200106
1988;474(1):86-93.
117. McLarnon JG. Correlated inflammatory responses and
doi: 10.1016/0006-8993(88)90671-3
neurodegeneration in peptide-injected animal models of
107. Liu B, Liu J, Shi JS. SAMP8 mice as a model of age- Alzheimer’s disease. Biomed Res Int. 2014;2014:923670.
related cognition decline with underlying mechanisms in doi: 10.1155/2014/923670
Alzheimer’s disease. J Alzheimers Dis. 2020;75(2):385-395.
118. Zhang HY, Yan H, Tang XC. Huperzine A enhances the level
doi: 10.3233/JAD-200063
of secretory amyloid precursor protein and protein kinase
108. Capdevila J, Ducreux M, García Carbonero R, et al. C-alpha in intracerebroventricular beta-amyloid-(1-40)
Streptozotocin, 1982-2022: forty years from the FDA’s infused rats and human embryonic kidney 293 Swedish
approval to treat pancreatic neuroendocrine tumors. mutant cells. Neurosci Lett. 2004;360(1-2):21-24.
Neuroendocrinology. 2022;112(12):1155-1167.
doi: 10.1016/j.neulet.2004.01.055
doi: 10.1159/000524988
119. Shekarian M, Komaki A, Shahidi S, Sarihi A, Salehi I,
109. Mostafavinia A, Amini A, Ghorishi SK, Pouriran R, Raoufi S. The protective and therapeutic effects of
Bayat M. The effects of dosage and the routes of vinpocetine, a PDE1 inhibitor, on oxidative stress
administrations of streptozotocin and alloxan on induction and learning and memory impairment induced by an
rate of type1 diabetes mellitus and mortality rate in rats. intracerebroventricular (ICV) injection of amyloid beta
Lab Anim Res. 2016;32(3):160-165. (aβ) peptide. Behav Brain Res. 2020;383:112512.
doi: 10.5625/lar.2016.32.3.160 doi: 10.1016/j.bbr.2020.112512
110. Grieb P. Intracerebroventricular streptozotocin injections 120. Yin S, Ran Q, Yang J, Zhao Y, Li C. Nootropic effect of
as a model of Alzheimer’s disease: In search of a relevant neferine on aluminium chloride-induced Alzheimer’s

Volume 3 Issue 3 (2024) 18 doi: 10.36922/an.2903